ROBXF yields 2000000.00% · PFE yields 6.13%● Live data
📍 ROBXF pulled ahead of the other in Year 1
Combined, ROBXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ROBXF + PFE for your $10,000?
Robix Environmental Technologies, Inc., an investment holding company, develops and sells oil spill response and recovery equipment, oil-water separation equipment, and cleaning and purification equipment in Canada. The company operates through Clean Ocean Vessel Technology and Clean Water Technology segments. Its products include C series clean ocean vessel that recover oil in rough ocean waters, lakes, rivers, and tailings ponds; and P series platform, which accelerates oil recovery from settling ponds at production facilities, as well as hydro cycle water systems. Robix Environmental Technologies, Inc. also provides contaminated water clean-up treatment services. The company was formerly known as Robix Alternative Fuels, Inc. and changed its name to Robix Environmental Technologies, Inc. in March 2016. Robix Environmental Technologies, Inc. was founded in 2011 and is headquartered in Calgary, Canada. Robix Environmental Technologies, Inc. is a subsidiary of Blue Horizon Industries Inc.
Full ROBXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.